Earnings Outlook For VolitionRX
Portfolio Pulse from Benzinga Insights
VolitionRX (AMEX:VNRX) is scheduled to release its quarterly earnings report on Monday, 2024-03-25, with analysts expecting an EPS of $-0.11. The company's past earnings performance shows a mixed impact on its stock price, with the last quarter's beat leading to a 1.29% drop. Shares are currently trading at $0.73, down 56.57% over the last year, indicating a bearish sentiment among long-term shareholders.
March 22, 2024 | 2:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
VolitionRX is expected to report an EPS of $-0.11 for the upcoming quarter. Historical data shows mixed reactions to past earnings, with a recent drop despite beating estimates. The stock has significantly underperformed over the past year.
Given VolitionRX's history of mixed stock price reactions to earnings reports and the significant year-to-date decline, the short-term impact of the upcoming earnings report is uncertain. While a beat on expectations could provide a temporary boost, the overall bearish sentiment and focus on future guidance suggest a neutral outlook.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100